SCHEMBL9866473

SCHEMBL9866473

O=C(NC(=NCCCSc1ccccn1)NCCCc1c[nH]cn1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
NPC1 O15118 4/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
TP53 P04637 1/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
HRH2 P25021 3/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 2/20 0.37
HRH4 Q9H3N8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
SCN5A Q14524 1/20 0.34
SCN2A Q99250 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866479 0.96 RAB9A (0.42) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9865750 0.96 RAB9A (0.43) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9865765 0.94 RAB9A (0.47) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9866485 0.90 HRH4 (0.42) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL10369046 0.90 HRH4 (0.42) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL11080973 0.87 HRH2 (0.43) RAB9ANPC1HRH2HRH4SCN5A
SCHEMBL11080965 0.87 HRH2 (0.43) RAB9ANPC1HRH2HRH4SCN5A
SCHEMBL9867694 0.86 HRH2 (0.44) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL9865876 0.86 HPGD (0.46) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL9865867 0.86 HPGD (0.46) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed